Response to "Bridging the implementation gap in AI-assisted flow cytometry"
Cytometry B Clin Cytom
.
2026 Jan 21.
doi: 10.1002/cytob.70009.
Online ahead of print.
Authors
Alice Yue
1
,
Ryan R Brinkman
2
,
Veronica Nash
3
,
Fabian Junker
4
,
Goce Bogdanoski
5
,
Anagha Divekar
6
,
Aaron Tyznik
7
,
Josef Spidlen
8
,
Wolfgang Kern
9
,
Jordi Petriz
10
,
Kaska Wloka
11
,
Kamila Czechowska
12
Affiliations
1
Zhejiang University, Zhejiang, China.
2
Dotmatics, Boston, Massachusetts, USA.
3
GSK plc, Collegeville, Pennsylvania, USA.
4
Bright Peak Therapeutics, Allschwil, Switzerland.
5
Bristol Myers Squibb, Princeton, New Jersey, USA.
6
BioLegend, San Diego, California, USA.
7
Becton, Dickinson and Company, San Diego, California, USA.
8
Becton, Dickinson and Company, Ashland, Oregon, USA.
9
MLL Münchner Leukämielabor, Munich, Germany.
10
Germans Trias i Pujol Research Institute, Barcelona, Spain.
11
National Institutes of Health, Bethesda, Maryland, USA.
12
Department of Development, Metafora Biosystems, Paris, France.
PMID:
41562380
DOI:
10.1002/cytob.70009
No abstract available
Publication types
Letter